AU7444891A - New hiv p24 peptides, diagnostic antigens and discriminative immunoassay method - Google Patents
New hiv p24 peptides, diagnostic antigens and discriminative immunoassay methodInfo
- Publication number
- AU7444891A AU7444891A AU74448/91A AU7444891A AU7444891A AU 7444891 A AU7444891 A AU 7444891A AU 74448/91 A AU74448/91 A AU 74448/91A AU 7444891 A AU7444891 A AU 7444891A AU 7444891 A AU7444891 A AU 7444891A
- Authority
- AU
- Australia
- Prior art keywords
- discriminative
- peptides
- immunoassay method
- new hiv
- diagnostic antigens
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- AIDS & HIV (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9000595 | 1990-02-20 | ||
SE9000595A SE468168B (sv) | 1990-02-20 | 1990-02-20 | Hiv-1, p24 peptider, diagnostiska antigener och foerfarande foer saerskiljande diagnostik av preliminaert hiv-1 positiva serumprov |
Publications (1)
Publication Number | Publication Date |
---|---|
AU7444891A true AU7444891A (en) | 1991-09-18 |
Family
ID=20378616
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU74448/91A Abandoned AU7444891A (en) | 1990-02-20 | 1991-02-18 | New hiv p24 peptides, diagnostic antigens and discriminative immunoassay method |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU7444891A (sv) |
SE (1) | SE468168B (sv) |
WO (1) | WO1991013360A1 (sv) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4039925A1 (de) * | 1990-12-14 | 1992-06-17 | Behringwerke Ag | Ausgewaehlte peptide des gruppenspezifischen antigens (gag) von humanem immundefizienzvirus (hiv), ihre herstellung und verwendung |
SE9101863D0 (sv) * | 1991-06-13 | 1991-06-13 | Replico Medical Ab | Peptider, diagnostiskt antigen, vaccinkomposition och foerfarande foer selektering av hiv-stammar |
US6689879B2 (en) | 1998-12-31 | 2004-02-10 | Chiron Corporation | Modified HIV Env polypeptides |
AU2487300A (en) | 1998-12-31 | 2000-07-31 | Chiron Corporation | Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
NO311807B1 (no) | 1999-03-04 | 2002-01-28 | Bionor Immuno As | HIV-peptider, antigener, vaksinepreparater, immunoassay- testsett og en metode for påvisning av antistoffer fremkalt av HIV |
CN1635876A (zh) * | 2000-02-04 | 2005-07-06 | 杜克大学 | 人免疫缺陷病毒疫苗 |
NO314588B1 (no) | 2000-09-04 | 2003-04-14 | Bionor Immuno As | HIV-peptider, antigener, vaksinesammensetning, immunoassay- testsett og en fremgangsmåte for å påvise antistoffer indusert av HIV |
JP5033303B2 (ja) | 2001-07-05 | 2012-09-26 | ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド | 抗原性c型hivポリペプチドをコードするポリヌクレオチド、ポリペプチドおよびそれらの使用 |
US20030170614A1 (en) | 2001-08-31 | 2003-09-11 | Megede Jan Zur | Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof |
WO2013182660A1 (en) | 2012-06-06 | 2013-12-12 | Bionor Immuno As | Hiv vaccine |
JP2017523166A (ja) | 2014-07-11 | 2017-08-17 | ビオノール イミュノ エーエスBionor Immuno As | ヒト免疫不全ウイルスi(hiv)の病理学的影響を減少及び/若しくは遅延させるか又は後天性免疫不全症候群(aids)を発症するリスクを低減させる方法 |
US20180140694A1 (en) | 2015-05-04 | 2018-05-24 | Bionor Immuno As | Dosage regimen for hiv vaccine |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0387914B1 (en) * | 1984-10-18 | 1993-08-04 | Institut Pasteur | Envelope antigens of the human immuno-deficiency virus, and their applications |
AU594333B2 (en) * | 1985-04-08 | 1990-03-08 | Genetic Systems Corporation | Expression and diagnostic use of gag encoded peptides which are immunologically reactive with antibodies to lav |
EP0220273B2 (en) * | 1985-04-29 | 2007-01-17 | Bio-Rad Laboratories, Inc. | Synthetic antigens for the detection of aids-related disease |
US4808536A (en) * | 1986-02-27 | 1989-02-28 | Centocor, Inc. | Immunochemical method for detection of antibody against HTLV-III core protein based upon recombinant HTLV-III gag gene encoded protein |
NZ221440A (en) * | 1986-08-20 | 1991-11-26 | Genetic Systems Corp | Composition containing monoclonal antibodies/peptides useful in treating and diagnosing hiv infections |
CA1339363C (en) * | 1987-05-01 | 1997-08-26 | Alan Ray Flesher | Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use |
EP0330359A3 (en) * | 1988-02-25 | 1991-06-05 | Bio-Rad Laboratories, Inc. | Composition useful in the diagnosis and treating of hiv-1 infection |
AU641375B2 (en) * | 1988-12-20 | 1993-09-23 | Clarity Technologies Incorporated | Synthetic HIV-like peptides, their compositions and uses |
-
1990
- 1990-02-20 SE SE9000595A patent/SE468168B/sv unknown
-
1991
- 1991-02-18 WO PCT/SE1991/000114 patent/WO1991013360A1/en unknown
- 1991-02-18 AU AU74448/91A patent/AU7444891A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
SE9000595L (sv) | 1991-08-21 |
SE9000595D0 (sv) | 1990-02-20 |
WO1991013360A1 (en) | 1991-09-05 |
SE468168B (sv) | 1992-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4589289A (en) | Synthetic antigens, a process for the preparation thereof and the use thereof | |
AU2843889A (en) | Antigen antibody conjugate | |
AU1286988A (en) | Oil-in-water emulsions, a process for their preparation and their use | |
AU3180393A (en) | Improved sol capture immunoassay procedure | |
AU3570193A (en) | Altered antibodies, products and processes relating thereto | |
AU4958590A (en) | Novel derivatives of cyclosporine a, antibodies directed thereto and uses thereof | |
HK56395A (en) | Stack method and circuitry. | |
AU5267190A (en) | Modified antibodies | |
AU609981B2 (en) | Oil-in-water pesticidal emulsion, process for application | |
EP0345462A3 (en) | Immunoassay for hiv-1 antigens using f(ab')2 fragments as probe | |
AU616156B2 (en) | Monoclonal antibodies and peptides useful in treating and diagnosing HIV infections | |
AU5612686A (en) | Aids antigen, diagnosis and immunogenic compositions | |
AU7444891A (en) | New hiv p24 peptides, diagnostic antigens and discriminative immunoassay method | |
AU7465887A (en) | A fiber-containing product, a process for the preparation thereof, and the use thereof | |
AU6304590A (en) | Opaque and pearlescent, laminated and stretched products, and method for making them | |
AU6128990A (en) | Opaque, laminated and stretched products, and method for making them | |
AU5449590A (en) | Anti-hiv drug | |
AU2246788A (en) | Film folding device, method, and product | |
AU616667B2 (en) | Monoclonal antibodies against e7 protein of human type 16 papillomavirus, a process for their preparation, and their use | |
AU6214086A (en) | Monoclonal antibodies against tumour-associated glycoproteins, a process for their preparation and their use | |
AU4174789A (en) | Hybrid monoclonal antibodies, their production and use | |
AU3829189A (en) | Detecting antigens or antibodies | |
AU4817490A (en) | 2',3'-dideoxyribofuranosides and process for producing them | |
AU6887591A (en) | New hiv-1 p17 peptides, diagnostic antigens and immunoassay method | |
AU7588787A (en) | Preparation for immunoassay and method for producing the preparation |